Integrative Analysis of Cuproptosis‐Related Mitochondrial Depolarisation Genes for Prognostic Prediction in Non‐Small Cell Lung Cancer
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Guoqing Lyu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan Province, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mitochondria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xinxiang Social Sciences Association Research Project, Henan Science and Technology Department Scientific Research Fund, Joint Construction Project funded by Henan Provincial Health Committee and Henan Provincial Medical Science and Technology Program.
Abstract (Originalsprache)
In this research, we conducted an in‐depth analysis of differentially expressed genes associated with mitochondrial depolarisation in non‐small cell lung cancer (NSCLC) using single‐cell sequencing. By combining our findings with cuproptosis‐related genes, we identified 10 significant risk genes: DCN, PTHLH, CRYAB, HMGCS1, DSG3, ZFP36L2, SCAND1, NUDT4, NDUFA4L2 and RPL36A, using univariate Cox regression analysis and machine learning methods. These genes form the core of our prognosis risk prediction model, which demonstrated high specificity and accuracy in predicting patient outcomes, as evidenced by ROC curve analysis. Kaplan–Meier curves further confirmed that patients in the low‐risk group had significantly better survival rates compared to those in the high‐risk group. Our models also provided valuable insights into the tumour microenvironment, immunotherapy sensitivity and chemotherapy response. To facilitate the quantification of the probability of patient survival, we incorporated clinical data into a nomogram. We comprehensively analysed the mutation status and expression patterns of the 10 risk genes using bulk transcriptomic, single‐cell and spatial transcriptomic datasets. Drug target predictions highlighted DSG3, PTHLH, ZFP36L2, DCN and NDUFA4L2 as promising therapeutic targets. Notably, RPL36A emerged as a potential tumour marker for NSCLC, with its expression validated in lung cancer cell lines through qPCR. This study has established a predictive models based on mitochondrial depolarisation genes associated with cuproptosis, aiding clinicians in forecasting overall survival and guiding personalised treatment strategies. The identification of novel tumour markers has paved the way for targeted therapies, and therapeutic targets are critical for advancing the treatment of NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan Province, China.
- Life Science Center, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan Province, China.
- Key Laboratory for Leukemia Molecular Diagnosis and Treatment in Xinxiang City, Weihui, Henan Province, China.
- Key Laboratory for Lymphoma Molecular Diagnosis and Treatment in Xinxiang City, Weihui, Henan Province, China.
- Prenatal Diagnosis Center, Shanghai General Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, China.
- Beijing University of Chinese Medicine, Beijing, China.
ORCID-Profile: Jin-Cheng Guo
Förderung
- Xinxiang Social Sciences Association Research Project
- Henan Science and Technology Department Scientific Research Fund
- Joint Construction Project funded by Henan Provincial Health Committee and Henan Provincial Medical Science and Technology Program
- Postdoctoral research project in Henan Province
- Foreign expert project in Henan Province
Zitieren
APA
Lyu, G., Dai, L., Deng, X., Liu, X., Guo, Y., Zhang, Y., Wang, X., Huang, Y., Wu, S., Guo, J. C., & Liu, Y. (2025). Integrative Analysis of Cuproptosis‐Related Mitochondrial Depolarisation Genes for Prognostic Prediction in Non‐Small Cell Lung Cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70438
Vancouver
Lyu G, Dai L, Deng X, Liu X, Guo Y, Zhang Y, et al. Integrative Analysis of Cuproptosis‐Related Mitochondrial Depolarisation Genes for Prognostic Prediction in Non‐Small Cell Lung Cancer. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70438
BibTeX
@article{Lyu2025,
author = {Lyu, Guoqing and Dai, Lihua and Deng, Xin and Liu, Xiankai and Guo, Yan and Zhang, Yuan and Wang, Xiufeng and Huang, Yan and Wu, Sun and Guo, Jin-Cheng and Liu, Yanting},
title = {Integrative Analysis of Cuproptosis‐Related Mitochondrial Depolarisation Genes for Prognostic Prediction in Non‐Small Cell Lung Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70438}
}
EUVIMED